title: The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation.
authors.affiliation: NHS Centre for Reviews and Dissemination, University of York, UK.
authors.forename: R
authors.initials: R
authors.lastname: Lewis
authors.forename: A-M
authors.initials: AM
authors.lastname: Bagnall
authors.forename: S
authors.initials: S
authors.lastname: King
authors.forename: N
authors.initials: N
authors.lastname: Woolacott
authors.forename: C
authors.initials: C
authors.lastname: Forbes
authors.forename: L
authors.initials: L
authors.lastname: Shirran
authors.forename: S
authors.initials: S
authors.lastname: Duffy
authors.forename: J
authors.initials: J
authors.lastname: Kleijnen
authors.forename: G
authors.initials: G
authors.lastname: ter Riet
authors.forename: R
authors.initials: R
authors.lastname: Riemsma
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D019057:Quality-Adjusted Life Years; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D000077235:Vinorelbine
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D000077235:Vinorelbine